Hydroxychloroquine for COVID-19: a single center, retrospective cohort study
Introduction: The outbreak of coronavirus disease (COVID-19) in December 2019 called for a rapid solution, leading to repurposing of existing drugs. Due to its immunomodulatory effect and antiviral properties, hydroxychloroquine (HCQ) has been used in early 2020 for treatment of COVID-19 patients....
Main Authors: | Wen, Chung Ho, Yong, Wei Xin, How, Kang Nien, Khalid, Khairil Erwan, Zulkifli, Shazwani, Idris, Salmah |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine and Health Sciences, University Putra Malaysia
2022
|
Online Access: | http://psasir.upm.edu.my/id/eprint/101756/1/2023032211275502_MJMHS_0551.pdf |
Similar Items
-
Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020) -
Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study
by: Seah, Valerie Xue Fen, et al.
Published: (2024) -
Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic
by: Chai, Peter R., et al.
Published: (2020) -
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study
by: Yaffe, Michael, et al.
Published: (2023) -
Prediction of blood lactate values in critically ill patients: a retrospective multi-center cohort study
by: Mamandipoor, Behrooz, et al.
Published: (2022)